Danielle Brill Analyst PerformanceManaging Director at Truist FinancialDanielle Brill is a stock analyst at Truist Financial focused in the medical sector, covering 21 publicly traded companies. Over the past year, Danielle Brill has issued 11 stock ratings, including buy and hold recommendations. While full access to Danielle Brill's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Danielle Brill's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings39 Last 8 YearsBuy Recommendations94.87% 37 Buy RatingsCompanies Covered21 Unique Companies Ratings Distribution39RatingsDistribution of strong buy, buy, hold, and sell ratings by Danielle Brill.RatingPercentageCount Strong Buy0.0%0 ratings Buy94.9%37 ratings Hold5.1%2 ratings Sell0.0%0 ratingsOut of 39 total stock ratings issued by Danielle Brill at Truist Financial, the majority (94.9%) have been Buy recommendations, followed by 5.1% Hold.Best & Worst CallsBest Call0000.0%MNTASep 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%XLRNJul 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ95.2% of companies on NASDAQ20 companiesNYSE4.8% of companies on NYSE1 companyDanielle Brill, an analyst at Truist Financial, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical20 companies95.2%Finance1 company4.8%Danielle Brill of Truist Financial specializes in stock coverage within the Medical sector, with additional focus on Finance companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE11 companies52.4%PHARMACEUTICAL PREPARATIONS4 companies19.0%MED - DRUGS2 companies9.5%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC2 companies9.5%MED - GENERIC DRG1 company4.8%REAL ESTATE INVESTMENT TRUSTS1 company4.8% Danielle Brill's Ratings History at Truist Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPVLAPalvella Therapeutics10/2/2025Boost Price Target$61.75$80.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals9/2/2025Initiated Coverage$401.00Market Perform$0.0000.00% ROIHRMYHarmony Biosciences7/21/2025Initiated Coverage$35.20$48.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics7/21/2025Initiated Coverage$29.51$56.00Buy$0.0000.00% ROITECXTectonic Therapeutic7/21/2025Initiated Coverage$21.91$64.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences7/21/2025Initiated Coverage$132.02$163.00Buy$0.0000.00% ROIBBIOBridgeBio Pharma7/21/2025Initiated Coverage$46.51$66.00Buy$0.0000.00% ROICNTACentessa Pharmaceuticals7/21/2025Initiated Coverage$15.69$30.00Buy$0.0000.00% ROIJCAPJernigan Capital7/21/2025Initiated Coverage$16.70$24.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/21/2025Initiated Coverage$320.53$385.00Buy$0.0000.00% ROIIRONDisc Medicine7/21/2025Initiated Coverage$57.77$86.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
